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Introduction
Patients with mutations in the DMD gene have Duchenne 
muscular dystrophy (DMD), which is a progressive muscle 
degenerative disease that leads to loss of skeletal muscle cardio-
myopathy and eventual death (Bushby et al., 2010). In DMD, 
defective dystrophin protein causes muscle membrane fragility, 
leading to contraction-induced injury caused by high forces on 
the cell membrane and leading to cycles of muscle fiber degen-
eration and regeneration (Vetrone et al., 2009; Heydemann et 
al., 2009). Inflammatory cells invade in response to the repeated 
waves of damage and repair and release cytokines, which pro-
mote pathological fibrosis (Borthwick et al., 2013). Fibrosis 
leads to loss of mobility and function and has the potential to 
interfere with gene and stem cell therapies. Inflammatory cells 
also secrete promyogenic factors that enable proper myogenic 
differentiation and are absolutely necessary for successful mus-
cle repair (Cantini et al., 2002; Dumont and Frenette, 2010; 
Saclier et al., 2013). Thus, modulating the inflammatory cell 
infiltrate in dystrophic muscle has the potential to target both 
fibrosis and regeneration and represents a therapeutic target for 
DMD. Such treatment may attenuate disease and improve the 
efficacy of other therapies if used in combination.
Macrophages are the predominant immune cell type found 
in the inflammatory infiltrate of human DMD and mdx muscles 
(McDouall et al., 1990; Wehling et al., 2001). Macrophages that 
infiltrate dystrophic muscles are a heterogeneous mix of clas-
sically (M1) and alternatively (M2) activated types (Villalta et 
al., 2009; Mann et al., 2011). M1 macrophages are classified as 
proinflammatory because they express known proinflammatory 
mediators (tumor necrosis factor, interleukin [IL]-1β, and IL-6) 
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and reactive nitrogen and oxygen intermediates (Mantovani et 
al., 2007; Novak and Koh, 2013; Liu et al., 2014; Rigamonti et 
al., 2014). M1 macrophages have also been shown to promote 
myoblast proliferation and collagen production in fibroblasts 
in vitro (Song et al., 2000; Cantini et al., 2002). The alterna-
tively activated M2 macrophages, on the other hand, are a more 
heterogeneous group: M2 macrophages can be subdivided into 
M2a, M2b, and M2c macrophages (Liu et al., 2014; Rigamonti 
et al., 2014; Wermuth and Jimenez, 2015). M2a macrophages 
are believed to be fibrosis promoting (Song et al., 2000; Cantini 
et al., 2002), whereas M2c macrophages are thought to be de-
activating for M1 macrophages and pro-regenerative. Although 
the markers for M1 macrophages are fairly well defined, the 
markers to distinguish different subpopulations of M2 macro-
phages are less so, particularly M2c.
Osteopontin (OPN), encoded by the SPP1 gene, is the 
most highly up-regulated transcript in dystrophic muscles 
(Haslett et al., 2002; Porter et al., 2002). OPN is a multifunc-
tional protein that binds to a vast array of cell surface recep-
tors, (primarily integrins; Bayless et al., 1998; Casals et al., 
2008) to activate diverse signaling pathways including nuclear 
factor-κB and protein kinase B. Osteopontin activity has been 
shown to affect diverse cellular processes such as bone remod-
eling, cell motility, cell adhesion, and cell survival (Das et al., 
2005; Nyström et al., 2007; Kahles et al., 2014). Our prior work 
identified OPN as a potential immunomodulator that regulates 
fibrosis in the mouse model of DMD (Vetrone et al., 2009). In 
those studies, OPN ablation correlated with reduced muscle fi-
brosis, reduced TGF-β, and increased regeneration. Moreover, 
we found that OPN ablation altered the inflammatory milieu, 
leading to reductions in several immune cell populations such 
as natural killer T (NKT) cells and Gr-1+ cells, as well as an in-
crease in FoxP3 mRNA levels (a marker of regulatory T cells). 
However, the net effect of these changes in immune cell pop-
ulations and the specific manner in which OPN ablation alters 
dystrophic disease is not completely understood.
Here we elucidate how changes induced by OPN ablation af-
fect the pathogenesis of dystrophinopathies. The data show that OPN 
ablation skews dystrophic macrophages toward a pro-regenerative 
phenotype, leading to improved and sustained muscle mass and 
strength on long-term functional testing. This investigation pro-
vides insight into the role of OPN in dystrophic muscle and further 
substantiates its value as a therapeutic target for DMD.
Results
Role of NKT cells in the mdx phenotype
Our previous investigations demonstrated modulation of the 
mdx immune infiltrate after OPN ablation (Vetrone et al., 2009). 
In those studies, OPN ablation led to a significant decrease in 
the frequencies of intramuscular NKT and Gr-1+ cells invading 
mdx muscles (Vetrone et al., 2009). NKT cells are T cells that 
also express NK cell markers (e.g., NK1.1 or DX5; Godfrey 
and Kronenberg, 2004). These cells are activated by glycolip-
ids, which are presented in the context of membrane-bound 
CD1d molecules, akin to the manner in which T cells recognize 
peptides in the context of major histocompatibility complex 
(MHC) class I and II. To determine whether these cells are rel-
evant to the human disease, 10 biopsies from DMD boys rang-
ing from 3 to 9 yr of age were examined for evidence of NKT 
cells within the muscle tissue, by using an antibody against the 
invariant α chain (Vα24) expressed by human NKT cells. This 
analysis confirmed that scattered Vα24+ cells were present in 
the biopsies (Fig. 1 A).
To understand whether changes in NKT populations (such 
as those observed with OPN ablation) might underlie ameliora-
tion of the dystrophic phenotype, we conducted in vivo deple-
tion of NKT cells using an antibody against asialo-GM1, which 
was injected into mdx mice. Asialo-GM1 is a well-established 
cell surface ganglioside of NK and NKT cells that is necessary 
for their complete activation. Treatment with anti–asialo-GM1 
has been previously shown to result in a reduction of both cell 
types (Slifka et al., 2000; Nakagawa et al., 2001; Nakano et al., 
2002; Byrne et al., 2004). mdx mice were treated from 1 wk 
of age until they were assessed for functional and phenotypic 
features of muscular dystrophy at 4 and 24 wk of age. To verify 
that treatments were effective in depleting NKT cells, we evalu-
ated intramuscular NKT cells in treated mice, using tetramers of 
CD1d in conjunction with markers of NK and T cells (Fig. 1 B). 
Liver NKT cells were examined in parallel as a positive control. 
The analysis showed that GM1 treatment reduced intramuscular 
NKT cells (i.e., cells coexpressing CD3+, NK1.1+, and CD1d+ 
tetramer) by 85% (Fig. 1 B). Tetramer-negative NKT cells (i.e., 
cells expressing CD3+, NK1.1+, and CD1d−) were also depleted 
by GM1 treatment, by 83% (Fig. 1 B). In spite of reductions 
in NK and NKT cells, attenuation of intramuscular fibrosis or 
other features of the mdx phenotype was not observed at either 
Figure 1. NKT cells are observed in muscles 
from patients with Duchenne muscular dystro-
phy and are depleted from mdx muscle and 
liver by GM1 treatment. (A) Cross sections 
from DMD biopsies were immunostained with 
an antibody against Vα24, the invariant chain 
of human NKT cells. Positive staining appears 
red, and counterstain with hematoxylin labels 
the nuclei dark blue and the muscle tissue 
light blue. Bar, 100 µm. (B) Quantification of 
liver and muscle NKT cells from GM1- or PBS-
treated animals. The graph shows a represen-
tative experiment in which each bar represents 
the values obtained from pooled muscles 
isolated from three mice injected with PBS 
(blue bars) and three mice injected with GM1 
(black bars). The plot illustrates the frequency 
of CD3+ cells that coexpress either [NK1.1] 
or [NK1.1+ CD1d-tetramer]. Numbers shown 
represent the amount of depletion attained by 
GM1 treatment compared with PBS controls.
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the 4- or 24-wk time points (Table 1). Thus, the studies elim-
inate NKT cells as effectors of the dystrophic phenotype and 
suggest that the previously observed phenotypic improvements 
on OPN ablation were not a result of reductions in NKT cells.
Macrophage polarization is altered in the 
absence of OPN
Our prior studies demonstrated that the frequency of Gr-1+ cells 
(previously used as a Ly6G marker) was significantly reduced 
in OPN−/−mdx muscles (Vetrone et al., 2009). Because the Gr-1 
antibody recognizes both Ly6G (a neutrophil-specific marker) 
and Ly6C (a pan-granulocyte and macrophage marker) we 
sought to further explore the Gr-1+ cell types affected by OPN 
ablation. Double-staining of isolated mdx leukocytes with Gr-1 
and F4/80 antibodies revealed that neutrophils make up ∼7% of 
the total CD45+ leukocytes at 4 wk and 5 mo of age (Fig. 2 A), 
which is a smaller percentage of the leukocyte infiltrate than 
we had previously estimated (Vetrone et al., 2009). However, 
consistent with our prior results, the frequency of neutrophils 
was slightly decreased in OPN−/−mdx muscles (Fig.  2  A). 
Also consistent with our prior results, there was no change in 
the frequency of F4/80+ cells upon OPN ablation. To deter-
mine the frequency of eosinophils versus macrophages in the 
F4/80+ population, we stained for Siglec F, which is a marker 
of eosinophils. Eosinophils comprised ∼15% of all F4/80+ 
cells (Fig. 2 B), and their frequency was not altered in the ab-
sence of OPN (Fig. 2 B).
Examination of the Ly6C marker on isolated leukocytes 
revealed a striking shift in its distribution (between Ly6Clow vs. 
Ly6Chigh) in OPN−/−mdx mice (Fig. 3 A). Because Ly6C levels 
change from high to low as macrophages undergo polarization 
(Arnold et al., 2007; Varga et al., 2013; Crane et al., 2014), we 
reasoned that the altered Ly6C levels might reflect changes in 
macrophage subtypes. To determine whether the observed shift 
in Ly6C was caused by a change in macrophage polarization, 
we examined sorted F4/80+ cells from 4- and 8-wk-old mdx 
mice for expression of Ly6C. To obtain reproducible data, it was 
necessary to sort the F4/80+ cells and then exclude the eosino-
phils, based on side scatter height (SSC-H) and forward scat-
ter height (FSC-H) gating (Fig. 3 B). The macrophages were 
subsequently analyzed for Ly6C expression, which revealed 
the presence of three distinct populations: (a) F4/80lowLy6Chigh; 
(b) F4/80mediumLy6Cmedium; and (c) F4/80highLy6Clow (Fig. 3 C). 
Quantitative evaluation of these macrophage populations 
showed that the Ly6Chigh and Ly6Cmedium populations were 
significantly decreased in the OPN−/−mdx mice, whereas a sig-
nificant increase was observed in the Ly6Clow population in both 
4- and 8-wk-old OPN−/−mdx mice (Fig. 4). A similar tendency 
in skewing of macrophage polarization was also observed in 
an acute injury model with OPN ablation (Fig. S1). Thus, a 
consistent skewing of Ly6C was observed on isolated macro-
phages from OPN−/−mdx mice.
Levels of F4/80 and Ly6C correlate with 
M1, M2a, and M2c macrophage subtypes
To further characterize the phenotype of the macrophage pop-
ulations that we observed, we used FACS based on their Ly6C 
and F4/80 surface expression. After sorting, leukocytes from 
4- and 8-wk-old mdx mice were examined for gene expres-
sion profiles commonly associated with macrophage subtypes 
(Fig. 5). The F4/80lowLy6Chigh macrophages displayed high lev-
els of iNOS expression, with very little or no Arg-1, CD206, 
or CD163 expression, thus resembling M1 macrophages. The 
other two groups of macrophages, F4/80mediumLy6Cmedium and 
F4/80highLy6Clow, were both Arg-1+, CD206+, and CD163+, with 
little to no iNOS expression. However, the F4/80mediumLy6Cmedium 
group had the highest Arg-1 expression, suggesting that they 
resembled the M2a subtype, whereas F4/80highLy6Clow showed 
higher CD206 and CD163 expression and low Arg-1, suggest-
ing that these cells align with the profile of M2c macrophages. 
Thus, based on these expression profiles, we have defined 
F4/80lowLy6Chigh macrophages as M1, F4/80mediumLy6Cmedium as 
M2a, and F4/80highLy6Clow as M2c. These data reveal that OPN 
ablation in mdx mice alters macrophage polarization toward 
decreased M1 and M2a subtypes and increased M2c type mac-
rophages. Overall, the ratios of M1 to M2 are decreased at both 
4 and 8 wk of age (Fig. 5 C and Table S1).
OPN is a novel marker of M2c 
macrophages
We next examined whether OPN is differentially expressed in 
the three macrophage subtypes. Analysis of OPN expression 
in the sorted populations demonstrated that M2c macrophages 
express the highest levels of OPN compared with M1 and M2a 
subtypes, suggesting that OPN may be a novel and suitable 
marker for identification of M2c macrophages (Fig. 6). To fur-
ther characterize the expression of OPN in macrophage pop-
ulations, we evaluated OPN expression in a macrophage cell 
line that was induced to polarize according to defined macro-
phage phenotypes by exposure to specific cytokines. J774A.1 
Table 1. Functional and histological features of dystrophic mice treated with GM1
Characteristic 4 wk 6 mo
mdx-R.sera mdx-GM1 mdx-R.sera mdx-GM1
Mean ± SD n Mean ± SD n Mean ± SD n Mean ± SD n
Body weight, g 11.08 ± 2.2 30 11.61 ± 1.79 29 28.94 ± 4.46 11 29.93 ± 3.9 11
Wire test, seconds on wire 31.83 ± 10.6 23 33.46 ± 13.27 28 18.93 ± 10.76 11 15.6 ± 11.34 11
Creatine kinase, IU/L 25,039 ± 11,620 6 26,851 ± 8,997 6 10,745 ± 4,959 6 11,086 ± 3,789 6
Histopathology
Quadriceps, % necrotic area 8.04 ± 4.35 6 11.08 ± 5.39 8 3.71 ± 1.27 9 4.82 ± 2.66 9
Diaphragm, % necrotic area NA NA NA NA 6.69 ± 2.05 6 6.15 ± 2.22 6
NCAM, % positive fibers 5.11 ± 2.3 13 5.91 ± 3.03 12 NA NA NA NA
devMHC, % positive fibers 5.06 ± 1.61 9 6.79 ± 2.93 10 NA NA NA NA
NA, not applicable.
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macrophages were exposed to IFNγ, IL-4, or IL-10, and their 
expression of traditional macrophage polarization markers was 
assessed: inducible nitric oxide synthase (iNOS) for M1, Arg-1 
for M2a, and IL-10 for M2c macrophages (Fig. 7 A). We ob-
served that expression of iNOS, Arg-1, and IL-10 was induced 
by IFNγ, IL-4, and IL-10 treatment, respectively, suggesting 
that the macrophages polarized as expected; however, we ob-
served that IL-10 expression was also induced in cells treated 
with IFNγ, suggesting that IL-10 is not a specific M2c marker 
(Fig. 7 A). Additionally, we observed that OPN expression was 
specifically induced in M2c macrophages treated with IL-10, at 
both the RNA (Fig. 7 C) and protein (Fig. 7 D) levels, suggesting 
Figure 2. Analysis of Ly6C+ cells in OPN−/−mdx infiltrates. (A) Muscle leu-
kocytes were isolated from OPN−/−mdx and OPN+/+mdx muscles, stained 
for Gr1 and F4/80, and assessed by flow cytometry. FACS plots show 
F4/80 plotted against Gr1. Cells enclosed by the blue square represent 
neutrophils. The frequency of neutrophils is indicated in the top right of 
each quadrant. (B) Analysis of eosinophils was performed by Siglec F 
staining on sorted F4/80+ cells from OPN+/+mdx and OPN−/−mdx mus-
cles. Circled regions in the FACS plots represent the eosinophil population, 
and numbers indicate eosinophil frequencies (top). Bottom graphs show 
the quantification of F4/80+ cell frequency in the total intramuscular leuko-
cyte population (bottom left) and eosinophils in the intramuscular F4/80+ 
cell population (bottom right). Black bars represent OPN+/+mdx, and white 
bars represent OPN−/−mdx. Animal numbers are indicated on graphs. 
P-values were generated by Student’s t test. Vertical lines represent SEM.
Figure 3. Evaluation of macrophage polarization by cell sorting and 
FACS analysis. (A) Representative FACS plots of muscle-infiltrating leu-
kocytes stained for Ly6C and plotted against SSC for OPN+/+mdx and 
OPN−/−mdx. (B) Demonstration of the purity of MACS sorting. The top 
left FACS plot shows F4/80 staining of the negatively sorted population, 
and the top right FACS plot shows F4/80 staining of the positively sorted 
population. Positively sorted cells (arrow) were examined by SSC and FSC 
to isolate macrophages (larger population on the right) from eosinophils 
(left). The bottom right FACS plot shows Ly6C isotype control staining 
on the macrophage population used in these studies. (C) Representative 
FACS plots of MACS-sorted F4/80+ macrophages stained for F4/80 and 
Ly6C. Circled regions represent distinct macrophage populations. Exper-
iments were done at 4 and 8 wk of age. Quantification of these experi-
ments is shown in Fig. 4.
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that OPN is most highly expressed in this subtype of macro-
phage. The data show that OPN is a marker that distinguishes 
M2c macrophages from M1 and M2a types. To our knowledge, 
this finding suggests that OPN may represent the first specific 
M2c macrophage marker.
OPN ablation promotes the expression 
of pro-regenerative factors from mdx 
macrophages
Because the phenotype of tissue macrophages dictates the 
manner in which they influence a disease process, we sought to 
identify the functional outcome of the observed shift in mac-
rophage polarization in the setting of OPN ablation in mdx 
mice. To this end, we assessed the expression of profibrotic 
and pro-regenerative factors by RT-PCR on sorted F4/80+ cells 
isolated from OPN−/−mdx and OPN+/+mdx muscles. Based on 
the previous observations of reduced fibrosis in OPN−/−mdx 
muscles (Vetrone et al., 2009), we expected to detect a decrease 
in profibrotic cytokines such as TGF-β. However, no signifi-
cant differences were observed in the expression of different 
profibrotic factors such as fibronectin (Vidal et al., 2008), 
C-C chemokine ligand 17 (Belperio et al., 2004), and TGF-β 
(Vidal et al., 2008; Fig.  8  A). On the contrary, OPN−/−mdx 
macrophages showed significantly increased expression of 
pro-regenerative factors, such as insulin-like growth factor 1 
(Barton et al., 2002), leukemia inhibitory factor (Hunt et al., 
2013), and urokinase plasminogen activator (Suelves et al., 
2007; Fig.  8  B). Thus, OPN ablation appears to skew mac-
rophages toward a pro-regenerative macrophage phenotype 
in dystrophic muscles.
Figure 4. Macrophage polarization is 
skewed in OPN−/−mdx muscles. Quantifi-
cation of macrophage subpopulations from 
MACS-sorted F4/80+ macrophages isolated 
from OPN+/+mdx and OPN−/−mdx muscles. 
Plots depict mean values of pooled data from 
4-wk-old (top) and 8-wk-old (bottom) mice, 
assessed as described in Fig. 3. Vertical lines 
represent standard errors. Animal numbers are 
indicated on each bar of the graph. Statisti-
cal significance determined by Student’s t test. 
P-values are indicated.
Figure 5. Levels of F4/80 and Ly6C correlate 
with M1, M2a, and M2c macrophage sub-
types. Quantitative RT-PCR was used to eval-
uate mRNA expression of phenotypic markers 
from sorted macrophage populations isolated 
from muscles of 4-wk-old (A) or 8-wk-old (B) 
mice. Macrophage populations were defined 
and sorted (according to F4/80 and Ly6C lev-
els) from a single sample of pooled muscles 
collected from six 4-wk-old mice (A) and six 
8-wk-old mice (B). Samples were run in tripli-
cate to measure the expression of these genes. 
All values are expressed relative to GAP DH. 
(C) Graph of M1 vs M2 ratios at 4 and 8 wk 
of age. Vertical lines represent SEM.
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OPN ablation correlates with increased 
muscle mass and fiber diameter
The observed increase in pro-regenerative growth factors is consistent 
with our prior study of increased regenerating fibers in OPN−/−mdx 
muscles (Vetrone et al., 2009). To determine whether the observed 
shift toward a pro-regenerative macrophage phenotype on OPN ab-
lation leads to overall increases in muscle mass, we examined muscle 
weight and fiber diameter in the two genotypes of mice. Quadriceps 
muscles were carefully dissected and weighed, and the muscle weight 
was normalized to tibia length. This analysis showed a significant 
increase in quadriceps muscle mass at 3 mo, 6 mo, and 1 yr of age 
(Fig. 9). Extensor digitorum longus (EDL) muscle mass was also 
significantly increased at 6 mo of age (Fig. 9). Because the EDL 
is a small muscle with parallel fiber architecture, we also assessed 
the number of fibers and fiber diameter in this muscle. Although the 
number of fibers per cross-sectional area did not differ between gen-
otypes, we observed an overall increase in the fiber cross-sectional 
area in OPN−/−mdx EDL. Examination of the distribution of the fiber 
diameters revealed that the differences were in the smallest and larg-
est fibers, suggesting that two processes were being affected in the 
OPN−/−mdx: muscle regeneration and muscle growth.
OPN ablation induces long-term amelioration 
of the dystrophic phenotype in mdx mice
To determine whether the improvements in muscle mass that 
we observed led to long-term consequences for the health 
and function of dystrophic muscles, we performed nonin-
vasive functional muscle testing and physiological muscle 
strength tests on OPN−/−mdx and OPN+/+mdx mice over a 
long time course. These studies revealed that OPN ablation 
led to a sustained improvement in muscle strength in dys-
trophic mice (Fig.  10). OPN−/−mdx mice performed better 
on wire hanging (Fig. 10 A), grip strength (Fig. 10 B), and 
wire mesh (Fig. 10 C) tests, without large changes in body 
weight (Fig. 10 D). Physiological testing of single isolated 
EDL, soleus, and diaphragm muscles from OPN−/−mdx mice 
showed a significant increase in specific force (Fig.  10  E). 
Moreover, we observed significantly reduced serum creatine 
kinase (Fig. 10 F) and improved pulmonary function (based 
on improved minute ventilation and peak expiratory flow as 
shown in Fig.  10, G–I). Thus, these studies reveal that the 
pro-regenerative phenotype observed in OPN−/−mdx macro-
phages correlates with long-term improvements in muscle 
strength and function.
Discussion
In this investigation, we sought to understand the manner in 
which OPN ablation attenuates the severity of muscular dys-
trophy using the mdx mouse model. Several leukocyte popu-
lations were evaluated as a follow-up to our prior investigation 
in which we observed changes in NKT and Gr-1+ cells in 
OPN−/−mdx mice (Vetrone et al., 2009). Here we demonstrate 
that the reduced frequency of NKT cells on OPN ablation 
(Vetrone et al., 2009) does not contribute to the amelioration of 
dystrophic pathology: depletion of greater than 80% of NKT 
cells in mdx muscles did not improve phenotypic features of the 
disease (Table 1). Thus, our results confirm that these cells are 
not disease promoting in dystrophinopathies and that reductions 
in NKT cells do not play a causal role in the improvements that 
occur in OPN−/−mdx mice.
Figure 6. Assessment of OPN mRNA levels in FACS-sorted macrophage 
populations. Graph demonstrates data derived from quantitative RT-PCR of 
OPN mRNA from sorted macrophage subtypes. Macrophage populations 
were defined and sorted (according to F4/80 and Ly6C levels) from a sin-
gle sample of pooled muscles collected from six 8-wk-old mice and charac-
terized as shown in Fig. 5. Expression of OPN was normalized to GAP DH. 
Samples were run in triplicate to measure the expression of both genes.
Figure 7. In vitro polarization of macro-
phages reveals high expression of OPN in 
M2c macrophages. The J774A macrophage 
cell line was induced to different macrophage 
subtypes by exposure to polarizing cytokines 
in vitro to model macrophage polarization. 
Exposure to IFNγ polarizes to M1, exposure 
to IL4 polarizes to M2a, and exposure to IL10 
polarizes to M2c. NT, not treated. Polariz-
ing treatments are indicated under each bar 
of the graph. (A) Expression of iNOS (M1), 
Arg-1 (M2a), and IL-10 (M2c) was assessed 
by quantitative RT-PCR to confirm macrophage 
phenotype (top). (B) Quantitative RT-PCR as-
sessment of OPN mRNA expression in polar-
ized macrophages. Each bar in the plots from 
A and B represents the mean value calculated 
from six samples collected in three different ex-
periments. (C) Western blot of polarized mac-
rophage extracts reveals high OPN in M2c 
macrophages. Polarizing cytokines are indi-
cated above the lanes. Vertical bars represent 
standard error. P-values relative to nontreated 
cells are indicated based on Student’s t test.
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An important finding of this investigation is the role that 
we revealed for OPN in macrophage polarization in the setting 
of dystrophinopathy. Shifts in macrophage phenotypes have 
been previously proposed to influence the course of mdx dys-
trophy (Villalta et al., 2009, 2011a,b), whereby reductions in 
IFNγ, iNOS, or C-C chemokine receptor 2 reduce the M1/M2 
ratio and attenuate disease (Villalta et al., 2011a; Mojumdar et 
al., 2014), whereas IL-10 ablation increases the M1/M2 ratio 
and exacerbates disease (Villalta et al., 2011b). In agreement 
with the previous findings, we show here that the OPN abla-
tion-induced decrease in the M1/M2 ratio of mdx macrophages 
improves the dystrophic phenotype and increases muscle mass 
and strength. In addition, we identify OPN as a potential new 
marker of M2c macrophages. Our studies show that OPN is 
more specific than CD163 and IL-10 in identifying the M2c 
macrophage subtype, both in vivo and in vitro.
The increased muscle strength observed in this investiga-
tion is highly likely to be related to the significant increase in 
macrophage expression of pro-regenerative factors insulin-like 
growth factor 1 (Barton et al., 2002), leukemia inhibitory factor 
(Barton et al., 2002; Hunt et al., 2013), and urokinase plasmin-
ogen activator (Suelves et al., 2007; Bryer et al., 2008). At the 
same time, no significant difference was observed in the expres-
sion of profibrotic factors such as fibronectin (Vidal et al., 2008; 
To and Midwood, 2011), C-C chemokine ligand 17 (Belperio 
et al., 2004; Yogo et al., 2009), and TGF-β (Fig.  8). The in-
crease in pro-regenerative factors agrees with the relative shift 
toward M2c macrophages that we observed with OPN ablation, 
because M2c macrophages have been traditionally classified as 
the pro-regenerative macrophage subtype.
The effect of OPN ablation on macrophage polarization 
may be direct or indirect. OPN has been previously shown to 
suppress iNOS and IL-10 expression and induce IL-12, IL-6, 
tumor necrosis factor, and IL-1β expression in a variety of in 
vitro macrophage models (Rollo et al., 1996; Rollo and Den-
hardt, 1996; Ashkar et al., 2000; Koguchi et al., 2002; Weber 
et al., 2002; Naldini et al., 2006; Gao et al., 2007). Future 
studies are needed to gain insight into the specific relation-
ship between OPN and macrophage polarization in the con-
text of dystrophic muscles.
We previously observed reductions in TGF-β in muscles 
of OPN−/−mdx mice, but the results here reveal that alterations 
in TGF-β levels are not caused by the observed shift in mac-
rophage polarization. Magnetic-activated cell sorting (MACS) 
allowed us to more specifically evaluate the cytokine contri-
bution of macrophages to the dystrophic milieu and eliminate 
macrophages as the source of reduced TGF-β on OPN ablation. 
This result leaves us without an explanation for why OPN abla-
tion reduces TGF-β levels in dystrophic muscles. OPN biology 
is complex, and thus intensive studies on isolated cell types will 
be required to fully elucidate all of the pathways it regulates in 
dystrophic muscle. OPN binds to a large number of different in-
tegrins, as well as to the glycoprotein CD44, and may affect dif-
ferent cell types including fibroblasts (Goodison et al., 1999). 
OPN can also be retained intracellularly or posttranslationally 
modified by cleavage, phosphorylation, and glycosylation, thus 
adding complexity to understanding its role in dystrophy. More 
studies are necessary to fully understand which of its targets and 
signaling pathways are involved in DMD.
The changes induced in the macrophage population by 
OPN ablation correlated with improved muscle strength and 
function: OPN−/−mdx mice were stronger than OPN+/+mdx 
mice. mdx mice lacking OPN were able to hang 1.2–8 times 
longer than mdx mice when tested in the wire and mesh tests, at 
most ages tested. They also had less muscle damage, as shown 
by a significant decrease in serum creatine kinase levels. Addi-
tionally, we showed that OPN ablation in mdx mice improved 
respiratory function, suggesting that diaphragm muscle pathol-
ogy is reduced. Although there was a significant improvement 
in the dystrophic phenotype, OPN ablation does not restore 
mdx mice muscle strength back to normal (Fig. S2). We an-
ticipate that OPN inhibitors would be beneficial and could be 
used in combination therapy with other agents to slow disease 
progression and improve muscle function.
The complex biology of OPN and its multifaceted im-
pact on signaling pathways in different cells types may provide 
an explanation for conflicting studies about OPN as a disease 
modifier of DMD. Kyriakides et al. (2011) identified a single 
nucleotide polymorphism (SNP) in the promoter of the OPN 
gene (SPP1) that correlated with a more severe disease course, 
compared with the more common haplotype. The SNP is found 
in the AP1 binding site, very close to the translational start site 
of the protein. In that initial study, patients with the GG/TG 
SNP lost ambulation sooner than patients with the TT SNPs 
and expressed 2.7-fold higher levels of OPN. Although a few 
subsequent studies on this modifier were inconclusive, fol-
low-up study confirmed the modifier effect, but interestingly, 
the effect was observed only in steroid-treated patients (Bello 
Figure 8. OPN ablation promotes a pro-re-
generative macrophage phenotype. F4/80+ 
sorted macrophages were collected from 
8-wk-old mice and assessed by quantitative 
RT-PCR for profibrotic factors fibronectin, C-C 
chemokine ligand 17 (CCL17), and TGF-β 
(A) and pro-regenerative factors insulin-like 
growth factor 1 (IGF), leukemia inhibitory fac-
tor (LIF), and urokinase plasminogen activator 
(uPA). (B) Each sample was collected from a 
single mouse. The number of samples per ex-
periment is indicated on the bars. Vertical lines 
indicate SEM. P-values are shown based on 
Student’s t test comparison.
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et al., 2015). Studies in the dog model of DMD have demon-
strated that levels of OPN correlate with degree of disability in 
different muscles (Galindo et al., 2015). Therefore, modulation 
of OPN has been demonstrated in mice, dogs, and humans to 
affect disease progression.
This study suggests that modulating immune cell in-
filtrates toward a more pro-regenerative phenotype may slow 
down disease progression and improve muscle function in 
the dystrophinopathies. Furthermore, it provides insight into 
OPN-mediated mechanisms of mdx dystrophy and supports the 
development of OPN inhibitors to treat DMD.
Materials and methods
Animals
C57BL/6J, mdx (C57BL/10ScSn-Dmdmdx/J), and OPN-knockout mice 
(OPN-KO, B6.Cg-Spp1tm1Blh/J) were obtained from the Jackson Labo-
ratory. The mdx mice have a point mutation on exon 23 that generates 
a premature stop codon, leading to loss of expression of the full-length 
form of the dystrophin protein (Sicinski et al., 1989). On the other hand, 
OPN ablation in the OPN-KO mice was attained by replacing exons 4–7 of 
the SPP1 gene with the phosphoglycerokinase neomycin resistance gene 
(Liaw et al., 1998). OPN−/−mdx and OPN+/+mdx mice came from colonies 
previously established in the laboratory (Vetrone et al., 2009) by breeding 
male OPN-KO mice with homozygous mdx females, which later resulted 
in OPN+/−mdx mice that were crossed between them to obtain OPN−/−mdx 
and OPN+/+mdx mice. These colonies have been maintained in the Univer-
sity of California, Los Angeles (UCLA), vivarium by homozygous crosses. 
OPN−/−mdx and OPN+/+mdx colonies are in a mixed C57BL10/C57BL6 
background with a predominance of the C57BL10 background (∼60% as 
determined by congenic analysis). All mice used in these experiments were 
genotyped using previously published protocols (Amalfitano and Cham-
berlain, 1996; Liaw et al., 1998) for the OPN and dystrophin mutations, 
respectively. All animals were handled and bred according to guidelines 
stipulated by the Animal Research Committee at UCLA.
Intramuscular cardiotoxin injection
Quadriceps muscles from 3-mo-old C57BL/6J and OPN-KO mice 
were injected once with 100 µl of a 10-µM cardiotoxin solution (CTX; 
Figure 9. OPN ablation leads to increased 
muscle mass and size. The quadriceps and EDL 
muscles were evaluated for muscle mass at the 
ages indicated and data were normalized per 
tibial length. All cross sectional area and fiber 
analyses were conducted on the EDL. Vertical 
lines represent standard error. *, P < 0.05; 
#, P ≤ 0.02, determined by Student’s t test. 
Bars, 500 µm. CSA, cross-sectional area. Av-
erage fiber cross-sectional area was calculated 
from n = >9,000 fibers per genotype per age.
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cardiotoxin from Naja mossambica mossambica; Sigma-Aldrich) 
using a glass syringe (Hamilton Co.) with a 32-gauge needle (Hamilton 
Co.). CTX-injected muscles were dissected at 12, 24, 48, and 72 h after 
injection to be used for leukocyte isolation.
GM1 treatment of animals
Mdx mice were treated with an intraperitoneal injection of 30  µl of 
1.1-mg polyclonal anti-asialo GM1 (CL8955; Cedarlane Laboratories) 
or polyclonal rabbit sera as a control (Invitrogen) twice a week. For all 
studies, injections began at 6 d of age and continued until mice reached 
4 or 24 wk (6 mo) of age.
Wire test
Mice were tested by wire test as previously described (Vetrone et al., 
2009). In brief, mice were placed on a wire secured 2 feet above a safety 
net and allowed to use forelimbs and hindlimbs (but not tails) to hang. 
Each mouse was subjected to five trials, with 1 min of rest between tri-
als. Hang time was recorded from the moment the experimenter placed 
the mouse onto the wire until the mouse fell onto the safety net. The 
five data points were averaged and data expressed in seconds.
Grip strength
Forelimb grip strength was measured using a digital force gauge (DFIS 
2; Chatillon CE). Five trials were performed with 30 s of rest in be-
tween. In each trial, the mouse was allowed to grasp a metal rod and 
the technician slowly pulled the mouse by the tail until the digital gauge 
recorded the peak tension produced (in newtons [N]). Data are reported 
as a mean of the peak tension recorded in the five trials.
Wire mesh test
To assess overall muscle strength in vivo, mice were tested by wire mesh 
(custom built in the laboratory of M.J. Spencer). In brief, mice were 
placed in the center of a wire mesh pulled over a square wooden frame on 
a swivel. The apparatus was placed ∼1.5 ft over a cushioned floor. Once 
the mouse was in position, the wire mesh was rotated 180°, resulting in 
the mouse hanging upside down from the mesh. Because of the structure 
of the mesh, mice were only able to hang on to the mesh using their hind-
limb and forelimb paws. Hang time was recorded from the moment the 
experimenter began to rotate the mesh until the mouse fell off the mesh. 
Each mouse was subjected to five trials, with 1 min of rest between trials. 
The mean hang time across five trials was calculated for each mouse.
Isolated muscle mechanics
Muscle-specific force measurements from isolated EDL, soleus, and 
diaphragm muscles of 7-mo-old OPN+/+mdx and OPN−/−mdx mice 
were performed as previously described (Barton et al., 2010; Moor-
wood et al., 2013). In brief, mice were anesthetized with ketamine/
xylazine and executed; muscles were removed and placed in a bath of 
Ringer’s solution gas-equilibrated with 95% O2/5% CO2. Sutures were 
attached to the distal and proximal tendons of the EDL and soleus 
Figure 10. Long-term improvements in muscle strength observed by functional and physiological testing of OPN−/−mdx mice. (A) Hanging wire test (n = 
≥9 per genotype and age). (B) Grip strength test (n = ≥9 per genotype and age). (C) Wire mesh test (n = ≥10 per genotype and age). (D) Body weight (n 
= ≥9 per genotype and age). (E) Specific force (n indicated on bars of the graph). (F) Serum creatine kinase (n = ≥6 per genotype and age). (G) Minute 
ventilation (n = ≥10 per genotype and age). (H) Peak inspiratory flow (n = ≥10 per genotype and age). (I) Peak expiratory flow (n = ≥10 per genotype 
and age). Vertical lines represent standard error. *, P < 0.05; #, P ≤ 0.02, determined by analysis of variance model.
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muscles and to the central tendon and rib of the diaphragm prepara-
tions. Muscles were subjected to isolated mechanical measurements 
using a previously described device (Aurora Scientific; Barton et 
al., 2005) and bathed in Ringer’s solution gas-equilibrated with 95% 
O2/5% CO2. After determining optimum length (Lo) by supramaximal 
twitch stimulation, maximum isometric tetanus was measured in the 
muscles during a 500-ms stimulation. Upon completion of these mea-
surements, samples were rinsed in PBS, blotted, and weighed. Muscle 
cross-sectional areas were determined using the following formula: 
CSA = m/(Lo × L/Lo × 1.06 g/cm3), where m is muscle mass, Lo is 
muscle length, L/Lo is the ratio of fiber length to muscle length, and 
1.06 is the density of muscle.
Whole-body plethysmography
Respiratory function was measured in conscious, unrestrained mice using 
a whole-body plethysmograph (Buxco, Data Sciences International). In 
this system, mice are placed in a chamber that allows them to breathe natu-
rally, unrestrained and untethered. The system measures the small changes 
in the air that is exchanged in and out of the entire chamber because of 
the animal’s respiration (box flow). Each chamber was calibrated before 
every experiment, selecting the most appropriate response observed in 
FinePoint Software (Buxco, Data Sciences International) to the injection 
of 1 ml air into the chambers. Once all chambers were calibrated, mice 
were placed into chambers and allowed to acclimate for 55 min. A Bias 
Flow Regulator (Buxco, Data Sciences International) was used to prevent 
a rise in CO2 concentration during the acclimation and room air breathing 
periods. After acclimation, baseline respiratory function was measured for 
5 min. Subsequently, mice were subjected to two hypercapnic challenges 
in which a flow of 1 ml/min of 8% CO2/21% O2/balance N2 (Praxair) was 
injected for 5 min into the chamber. Between the two hypercapnic chal-
lenges, mice were allowed to return to room air breathing for 10 min to 
evaluate their capability to recover. All data were collected and analyzed 
using FinePoint Software, which uses complicated algorithms that include 
variables affecting respiratory function, such as humidity and temperature, 
to calculate from the measured box flow the physiological values of the 
respiratory parameters from the animal. Mice were weighed before the 
beginning of the experiment. Minute ventilation and peak flow values were 
normalized to body weight.
Serum creatine kinase
Blood samples were collected by retroorbital puncture using heparinized 
capillary tubes and transferred to serum-separating tubes. Samples were 
kept at RT for 15 min to allow the blood to clot and then centrifuged at 
3,400 g for 10 min to separate the serum. Once separated, serum was 
collected and stored at −80°C.  Creatine kinase activity in blood was 
estimated using the Creatine Kinase-SL kit from Sekisui Diagnostics, 
according to the manufacturer’s instructions. In brief, serum samples 
were diluted 1:50 (vol/vol) with sterile Ca2+,Mg2+-free PBS. Controls 
for this test were established using the commercial control serums DC-
TROL level-1 and level-2 (Sekisui Diagnostics). Samples and controls 
were set in triplicate in a 96-well plate and mixed with the reaction 
buffers provided in the kit. Absorbance of the samples was measured at 
340 nm using a Synergy HT multidetection microplate reader (Biotek 
Instruments). Creatine kinase concentration was reported in units per 
liter and calculated using the following equation:
  CK (U/L) =    ΔAbs × TV × 1, 000   _______________d × ε × SV  , 
where ΔAbs = mean absorbance change per minute; TV = total reaction 
volume (ml); d = light path (cm); ε = millimolar absorptivity of NADH 
(6.22); SV = sample volume (ml); and 1,000 = conversion of U/ml to U/l.
Muscle-infiltrating leukocyte isolation
Mice were sacrificed, and all muscles (hindlimb, pectoralis, diaphragm, 
and abdominal) from each mouse were collected and pooled together 
into a Petri dish containing sterile Ca2+,Mg2+-free PBS. Tissues were 
washed twice with sterile Ca2+,Mg2+-free PBS and then minced and 
digested into collagenase type 2 (Worthington Biochemical Corp.) solu-
tion (1,700 U/ml) at 37°C with slow agitation. Once the tissue was 
digested, the sample volume was raised with sterile Ca2+,Mg2+-free PBS 
to stop the digestion and passed through a 70-µm cell strainer. Cells 
were pelleted by centrifugation of the filtered mix at 900 g for 5 min. 
Supernatant was discarded, and the pellet was resuspended in ammo-
nium-chloride-potassium lysing buffer for 5 min to lyse the red blood 
cells. The lysing process was then stopped by raising the volume of the 
sample with sterile Ca2+,Mg2+-free PBS, and the suspension was cen-
trifuged at 900 g for 5 min to collect the cells. The cell pellet was sus-
pended again in sterile Ca2+,Mg2+-free PBS and passed through a 40-µm 
cell strainer. The filtered cell suspension was then centrifuged at 900 g 
for 5 min, the supernatant was discarded, and the cell pellet was resus-
pended in a small volume of sterile Ca2+,Mg2+-free PBS. At this point, a 
small fraction of the sample was mixed 1:1 with 0.4% Trypan blue solu-
tion, and the number of unstained cells in the sample was counted using 
a hemocytometer. The concentration of viable cells in the sample and 
the total number of viable cells was then assessed using the following 
formulas: viable cells/ml = unstained number of cells × dilution factor 
× 104; total viable cells = viable cells/ml × final volume of the sample.
MACS of isolated macrophages
Macrophage isolation from the total leukocyte population was per-
formed using Miltenyi Biotec MACS technology. Isolated intramus-
cular leukocyte samples were first blocked with an antibody against 
CD16/CD32 (anti-mouse, clone 93; Biolegend) to decrease nonspecific 
labeling and then stained with fluorescently labeled anti-F4/80 (rat 
anti-mouse, clone BM8, either PE- or APC-labeled; eBioscience). We 
used the company protocol for cell labeling and separation, with mag-
netic nanoparticles coated with antibodies against the fluorescent label 
used for the primary antibody (either anti-PE– or anti-APC–coated mi-
crobeads; Miltenyi Biotec).
FACS of isolated macrophages
MACS-sorted F4/80+ samples were labeled with fluorescently tagged 
antibodies against Ly6C (rat anti-mouse, Clone HK1.4; Biolegend), 
Siglec-F (rat anti-mouse, clone E50-2440; BD Biosciences), or their 
respective isotype controls (Rat IgG2c,K and Rat IgG2a,k, respec-
tively). Fluorescently labeled samples were sorted using a FACScalibur 
(Becton Dickinson) flow cytometer. Acquisition parameters (voltage, 
gain, etc.) were adjusted with aliquots of the same samples to obtain 
the maximum dynamic range of SSC-H, FSC-H, and fluorescence (at 
the different channels). FACS acquisition files were analyzed using 
FlowJo analysis software.
Macrophage subtype isolation using FACS
Six 4-wk-old and six 8-wk-old OPN+/+mdx mice were used to isolated 
the individual macrophage subtype populations. Muscles (hindlimb, 
pectoralis, diaphragm, and abdominal) from all six mice were pooled 
together, and intramuscular leukocyte isolation was performed as de-
scribed earlier. Isolated intramuscular leukocyte samples were first 
blocked with an antibody against CD16/CD32 (anti-mouse, clone 93; 
Biolegend) to decrease nonspecific labeling and then dually stained with 
anti-F4/80-APC (rat anti-mouse, clone BM8; eBioscience) and anti–
Ly6C-FITC (rat anti-mouse, clone HK1.4; Biolegend). Fluorescently 
labeled samples were sorted using a FAC SAR IA III (Becton Dickin-
son). Unlabeled samples were used as control. Acquisition parameters 
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(voltage, gain, etc.) were adjusted with aliquots of the same samples to 
obtain the maximum dynamic range of SSC-H, FSC-H, and fluores-
cence (at the different channels). Macrophage population limits were 
established using gates resembling those of the analytical experiments.
Macrophage culture and polarization treatments
The murine monocyte/macrophage cell line J774A.1 (ATCC) was 
used as the in vitro macrophage model. Macrophages were grown and 
maintained in macrophage growth medium (DMEM, 1% penicillin/
streptomycin, and 10% FBS), and subculture was prepared by scrap-
ing. Macrophage polarization was attained by incubation of the mac-
rophage cultures with growth medium supplemented with 100 ng/ml 
murine IFNγ, IL-4, or IL-10 (BD) to polarize the cultures to M1, M2a, 
or M2c macrophages, respectively.
Isolation of liver NKT cells
Livers were removed and dissociated using the end of a 5-cc syringe 
plunger and a 70-µM cell strainer. Cell suspensions were centrifuged at 
900 g for 6 min at RT. Cell pellets were resuspended in 0.85% ammo-
nium chloride and incubated at RT for 10 min to lyse red blood cells. 
After incubation, suspensions were diluted with Dulbecco’s PBS with-
out Ca+ and Mg+ (Invitrogen) to stop the lysing process and centrifuged 
for 6 min at 900 g. Pellets were resuspended in 40% Percoll and loaded 
to the top of a Percoll gradient (70% Percoll at bottom and 40% at top). 
Tubes were then centrifuged at RT for 20 min at 2,000 rpm. The cells at 
the interface were collected and washed, and the resulting pellets were 
resuspended in PBS and counted.
Antibody staining for flow cytometry of NKT cells
Muscle leukocyte suspensions were incubated with anti-CD16/CD32 
(anti-mouse, clone 2.4G2; BD) to block binding to Fc receptors be-
fore staining. The following mouse mAbs used for staining were all 
obtained from BD: CD3e (hamster anti-mouse, clone 145-2C11), 
Vβ8.1/8.2 (mouse anti-mouse, clone MR5-2), NK1.1 (mouse anti- 
mouse, clone PK136), and pan-NK (rat anti-mouse, clone DX5). An-
tibodies were conjugated to FITC, PE, and/or Cy5. The following 
antibodies were biotinylated and revealed with Tricolor-conjugated 
streptavidin (Ebioscience): anti–asialo-GM1 (CL8955; Cedarlane Lab-
oratories) or rabbit sera (control; Invitrogen). Optimal working dilu-
tions were determined for each antibody before use. All incubations 
were performed in Ca+,Mg+-free Dulbecco’s PBS (Invitrogen) at 4°C 
for 30 min. After the last wash, 103 live cells per sample were acquired 
on a FACScalibur (Becton Dickinson) and analyzed with CELL Quest 
Pro software (Becton Dickinson). CD1d tetramers were obtained from 
the National Institutes of Health Tetramer Core Facility.
Immunohistochemistry
Muscles were dissected, placed on balsa wood, coated with Tissue Tek 
O.C.T. (optimal cutting temperature; Sakura Finetek) mounting media, 
and frozen in isopentane cooled by liquid nitrogen. Diaphragm muscles 
were cut in half down the midline and rolled before freezing. Sections 
were cut on a Micron HM 505E cryostat (10 µm thick; Micron In-
struments) and stored at −20°C until use. Immunohistochemistry was 
performed as previously described (Kramerova et al., 2004). In brief, 
sections were thawed at RT for 30 min then treated with 0.3% H2O2 
for 5 min and blocked in PBS with 0.2% gelatin, 0.5% Tween-20, and 
3% BSA for 30 min. When necessary, binding to endogenous mouse 
IgG was blocked with a mouse on mouse kit (MOM; Vector Labora-
tories). Sections were later incubated with antibodies against T cell 
receptor Vα24 (eBioscience) to identify NKT cells in human biopsies, 
CD11b (clone M1/70; BD Biosciences) to emphasize areas of inflam-
mation, or stained with neural cell adhesion molecule (NCAM; clone 
H28.123; Chemicon International) or developmental myosin heavy 
chain (devMHC, clone RNMy2/9D2; Novacastra) to emphasize regen-
erating fibers. Biotin-conjugated antibodies (Vector Laboratories) were 
used as secondary antibodies, followed by incubation with avidin-con-
jugated horseradish peroxidase and staining with the AEC substrate kit 
(Vector Laboratories). To evaluate the cross-sectional area of muscles 
and fibers, muscle sections were immunolabeled with laminin antibod-
ies. Sections were thawed at RT for 30 min, washed in PBS, blocked 
in PBS with 0.2% gelatin, 0.5% Tween-20, and 3% BSA for 30 min, 
incubated with anti-laminin antibody (L9393; Sigma-Aldrich) for 1 h, 
washed in PBS, and incubated with fluorescein anti-rabbit antibody 
(Vector Laboratories) for 1 h. Finally, sections were washed in PBS, 
fixed with 2% paraformaldehyde solution for 10 min, washed again in 
PBS, and mounted with DAPI mounting media (Vector Laboratories). 
Muscle sections were imaged using an Axio Imager M1 microscope 
(ZEI SS) equipped with an AxioCam HRc camera (ZEI SS). Mosaic 
images of the muscle sections were taken using a 10× EC Plan-NEO 
FLU AR objective (NA 0.3; ZEI SS) and zoomed images were acquired 
using a 20× EC Plan-NEO FLU AR objective (NA 0.5; ZEI SS). Images 
were acquired, processed, and analyzed using the proprietary software 
Axiovision 4.8.1 (ZEI SS).
Histopathology index
Muscle necrosis was quantified from the muscle sections labeled with 
anti-CD11b antibody as the sum of the labeled (CD11b+) areas in a sec-
tion, normalized by the total cross-sectional area of the muscle section. 
Similarly, muscle regeneration was evaluated from the muscle sec-
tions labeled with anti-NCAM or anti-devMHC antibodies by count-
ing the number of both small-diameter myotubes and large-diameter 
regenerating myofibers positively labeled with NCAM or devMHC, 
and normalizing this by the total cross-sectional area of the muscle. 
Cross-sectional areas were measured using Axiovision 4.8.1. All anal-
yses were performed blindly.
Western blot
Cell culture samples were lysed in reducing sample buffer (50  mM 
Tris-HCl, pH 6.8, 10% glycerol, 2% SDS, and 100 mM β-mercaptoeth-
anol) supplemented with protease and phosphatase inhibitors. Bro-
mophenol blue (0.1%) was added, and samples were boiled at 100°C 
for 5 min for protein denaturation. SDS-PAGE and Western blotting 
were performed as previously described (Kramerova et al., 2004). 
BenchMark protein ladder was used as a molecular weight marker in 
every gel. Proteins were separated by gel electrophoresis and trans-
ferred into a nitrocellulose membrane. Membranes were blocked with 
5% milk in TBS-T (Tris-buffered saline, 0.1% Tween) and incubated 
with 1:500 anti-mouse OPN antibody (AF808; R&D Systems) solu-
tion in 5% milk TBS-T overnight at 4°C.  Membranes were washed 
and incubated with HRP-conjugated secondary antibody in 5% milk 
TBS-T. The chemiluminescence substrate kit, ChemiGlow West (Pro-
tein Simple), was used to detect the protein bands. Chemiluminescent 
signals were detected and densitometry analyzed using the FluorChem 
FC2 system (Alpha Innotech).
Quantitative RT-PCR
RNA was isolated and quantitative RT-PCR performed as previously 
described (Ermolova et al., 2014). In brief, total RNA was isolated from 
cell cultures and isolated cells using Trizol reagent (Invitrogen) ac-
cording to the manufacturer’s protocol. Genomic DNA contamination 
was removed by DNase I treatment (Invitrogen). To synthesize cDNA, 
1.5 µg of DNA-free RNA was used for first-strand cDNA synthesis 
with random hexamer primers and Superscript III reverse transcrip-
tion (Invitrogen) according to the company’s protocol. The resulting 
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cDNAs were used for PCR amplification using the primers sequences 
detailed in Table S2. Quantitative PCR reaction was set using the iTaq 
universal SYBR green supermix (Bio-Rad) according to the manu-
facturer’s protocol. PCR product formation was evaluated using the 
CFX-Connect Real Time System (Bio-Rad).
Statistical analysis
Means were compared by genotype and age using a factorial analysis 
of variance model in which variances were allowed to be heteroge-
neous, since variance homogeneity did not hold. For pulmonary out-
comes in which the same animal was exposed to CO2 and room air 
conditions, means were compared by genotype and condition using 
a repeated-measure analysis of variance model (mixed model). Post 
hoc (under the model) p-values were computed using the Fisher least 
significant difference criterion. Residual error normal quartile plots 
were examined to confirm that the residual errors followed a normal 
distribution, allowing the use of a parametric model. Student’s t test 
or Mann–Whitney U test were used for experiments using only two 
groups. Values were considered significantly different if P ≤ 0.05.
Online supplemental material
Fig. S1 shows the effect of OPN ablation on macrophage polarization in 
acute injury experiments (CTX injection experiments). Fig. S2 provides 
information about the degree of improvement caused by OPN ablation in 
mdx mice by comparing the performance of C57BL/6J and OPN−/−mdx 
mice in different muscle strength tests. Table S1 provides the total cell 
number in the different macrophage subtypes per muscle mass, from the 
experiments shown in Fig. 4 for 8-wk-old mice. Table S2 summarizes 
the sequences of the primers used. Online supplemental material is 
available at http ://www .jcb .org /cgi /content /full /jcb .201510086 /DC1.
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